< Back to previous pageProject Development of an innovative platform for generation of tailor-made fully human therapeutic monoclonal antibodies against human targets Date:1 Jan 2010 → 31 Dec 2013 Keywords:AntilichamenResearchersMarc Jacquemin (Promoter)Centre for Molecular and Vascular BiologyDuration: 1 Jan 2010 → 31 Dec 2013Project partnersCentre for Molecular and Vascular Biology (Division)From1 Jan 2010 → 31 Dec 2013KU LeuvenFunding1 - 1 of 1 resultsFunding: SBO (Strategic basic research)(Principal funding)Funding party: Flanders Innovation & EntrepreneurshipPolicy level funding: Flemish
